
Osteoarthritis Market Size, Share, and Analysis, By Type (Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis), By Drug Type (Analgesics, Corticosteroids, Viscosupplementation agents, Nonste
Description
Osteoarthritis Market Size, Share, and Analysis, By Type (Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis), By Drug Type (Analgesics, Corticosteroids, Viscosupplementation agents, Nonsteroidal anti-inflammatory drugs {NSAIDS}), By Diagnosis (Imagining and Joint Fluid Analysis), By Route of Administration (Parenteral Route, Oral Route, Topical Route), By Treatment (Medication, Therapy, Surgery), By Distribution Channel (Hospitals Pharmacy, E-Commerce, Retail Pharmacy, Drug Store), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW
The global Osteoarthritis market size was USD 5.85 billion in 2021 and projected to grow from USD 6.9 billion in 2023 to USD 15 billion by 2032, exhibiting a CAGR of 9.0% during the forecast period
Osteoarthritis (OA) is a common condition which affects the shoulders, fingers, knees, feet, back, hips, and neck joints. The progressive deterioration of the joint cartilage is its characteristic. OA can be identified through X-ray, medical assessment, lab tests, arthroscopic, joint fluid analysis, and magnetic resonance imaging (MRI) scans. Several surgical methods & drugs are preferred to treat the indications and symptoms. Few symptoms of OA are stiffness, discomfort, oedema, lack of flexibility, chronic pain, bone spurs, and sleep disruptions. The poor dietary habits, sedentary lifestyle, increased obesity and blood sugar levels are a major reason for acquiring OA.
MARKET HIGHLIGHTS
Osteoarthritis Market is expected to project a CAGR of 9.0% during forecast period, 2022-2032
Osteoarthritis market is expected to reach USD 15 billion at a CAGR of 9.0% during forecast period owing to the increasing awareness about Osteoarthritis and the accessibility to advanced treatments are boosting the growth of osteoarthritis treatment. The increasing demand for minimal invasive non-surgical treatments assist in the growth of the osteoarthritis market.
OSTEOARTHRITIS MARKET SEGMENTATION:
Spinal Osteoarthritis segment is expected to dominate during the forecast period
Osteoarthritis Market is classified based on the Type into Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis. Spinal Osteoarthritis segment is expected to dominate market during the forecast period owing to the increasing acquirance of sedentary lifestyles, rising obesity rates which is expected to drive the spinal osteoarthritis market growth. The rising preference of minimal invasive procedures of surgery and the advancements of new treatments are aiding in the growth of the market.
Imagining segment is expected to dominate during the forecast period
MARKET DYNAMICS:
Growth Drivers
- Growing Demand for Osteoarthritis Products is Expected to Drive Market Growth
- Expansion of New Therapies is Expected to Boost the Market Growth
- Incidence of Cardiovascular Diseases May Restrain the Market Growth
OSTEOARTHRITIS MARKET:
- Pfizer Inc
- Abbott
- Novartis AG
- Eli Lilly and Company
- Bayer AG
- Johnson & Johnson
- ABIOGEN PHARMA S.p.A
- Merck Sharp & Dohme Corp.
- Apotex Inc.
- TissueGene Inc.
- Ampio Pharmaceuticals Inc.
- Mylan N.V.
- Tolmar Pharmaceuticals, Inc.
- Other Prominent Players
Osteoarthritis Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America region dominated the Osteoarthritis Market in 2021 and is also expected to dominate over the forecast period owing to the increasing awareness on osteoarthritis and the growing investments in research and development field by pharma companies which is assisting to the osteoarthritis market growth in this region. The acquisition of modern technologies of medicine and the presence of major market players are expected to drive the growth of the market. The pipeline development of OA market is strong with new developments which is further expected to boost the growth of the market.
Segmentation
Type
- Hip Osteoarthritis
- Knee Osteoarthritis
- Foot & Ankle Osteoarthritis
- Shoulder Osteoarthritis
- Spinal Osteoarthritis
- Analgesics
- Corticosteroids
- Viscosupplementation agents
- Nonsteroidal anti-inflammatory drugs (NSAIDS)
- Imagining
- Joint Fluid Analysis
- Oral Route
- Topical Route
- Medication
- Therapy
- Surgery
- Hospitals Pharmacy
- E-Commerce
- Retail Pharmacy
- Drug Store
- Prescription Drugs
- Over-The-Counter Drugs
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
Table of Contents
410 Pages
- 1 Executive Summary
- 1.1. Regional Market Share
- 1.2. Business Trends
- 1.3. Osteoarthritis Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2 Research Methodology
- 2.1. Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1. Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3 Market Characteristics
- 3.1. Market Definition
- 3.2. Osteoarthritis Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4 Osteoarthritis Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5 Macroeconomic Indicators
- 6 Recent Developments
- 7 Market Dynamics
- 7.1. Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4. Market Restraints
- 7.5. Market Trends
- 8 Risk Analysis
- 9 Market Analysis
- 9.1. Porters Five Forces
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10 Osteoarthritis Market
- 10.1. Overview
- 10.2. Historical Analysis (2016-2020)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11 Osteoarthritis Market Size & Forecast 2022A-2032F
- 11.1. Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1. By Type
- 11.3.1.1. Hip Osteoarthritis
- 11.3.1.1.1. By Value (USD Million) 2022-2032F
- 11.3.1.1.2. Market Share (%) 2022-2032F
- 11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.2. Knee Osteoarthritis
- 11.3.1.2.1. By Value (USD Million) 2022-2032F
- 11.3.1.2.2. Market Share (%) 2022-2032F
- 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.3. Foot & Ankle Osteoarthritis
- 11.3.1.3.1. By Value (USD Million) 2022-2032F
- 11.3.1.3.2. Market Share (%) 2022-2032F
- 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.4. Shoulder Osteoarthritis
- 11.3.1.4.1. By Value (USD Million) 2022-2032F
- 11.3.1.4.2. Market Share (%) 2022-2032F
- 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.5. Spinal Osteoarthritis
- 11.3.1.5.1. By Value (USD Million) 2022-2032F
- 11.3.1.5.2. Market Share (%) 2022-2032F
- 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2. By Drug Type
- 11.3.2.1. Analgesics
- 11.3.2.1.1. By Value (USD Million) 2022-2032F
- 11.3.2.1.2. Market Share (%) 2022-2032F
- 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.2. Corticosteroids
- 11.3.2.2.1. By Value (USD Million) 2022-2032F
- 11.3.2.2.2. Market Share (%) 2022-2032F
- 11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.3. Viscosupplementation agents
- 11.3.2.3.1. By Value (USD Million) 2022-2032F
- 11.3.2.3.2. Market Share (%) 2022-2032F
- 11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.4. Nonsteroidal anti-inflammatory drugs {NSAIDS}
- 11.3.2.4.1. By Value (USD Million) 2022-2032F
- 11.3.2.4.2. Market Share (%) 2022-2032F
- 11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3. By Diagnosis
- 11.3.3.1. Imagining
- 11.3.3.1.1. By Value (USD Million) 2022-2032F
- 11.3.3.1.2. Market Share (%) 2022-2032F
- 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.2. Joint Fluid Analysis
- 11.3.3.2.1. By Value (USD Million) 2022-2032F
- 11.3.3.2.2. Market Share (%) 2022-2032F
- 11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4. By Route of Administration
- 11.3.4.1. Parenteral Route
- 11.3.4.1.1. By Value (USD Million) 2022-2032F
- 11.3.4.1.2. Market Share (%) 2022-2032F
- 11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.2. Oral Route
- 11.3.4.2.1. By Value (USD Million) 2022-2032F
- 11.3.4.2.2. Market Share (%) 2022-2032F
- 11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.3. Topical Route
- 11.3.4.3.1. By Value (USD Million) 2022-2032F
- 11.3.4.3.2. Market Share (%) 2022-2032F
- 11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.5. By Treatment
- 11.3.5.1. Medication
- 11.3.5.1.1. By Value (USD Million) 2022-2032F
- 11.3.5.1.2. Market Share (%) 2022-2032F
- 11.3.5.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.5.2. Therapy
- 11.3.5.2.1. By Value (USD Million) 2022-2032F
- 11.3.5.2.2. Market Share (%) 2022-2032F
- 11.3.5.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.5.3. Surgery
- 11.3.5.3.1. By Value (USD Million) 2022-2032F
- 11.3.5.3.2. Market Share (%) 2022-2032F
- 11.3.5.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.6. By Distribution Channel
- 11.3.6.1. Hospitals Pharmacy
- 11.3.6.1.1. By Value (USD Million) 2022-2032F
- 11.3.6.1.2. Market Share (%) 2022-2032F
- 11.3.6.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.6.2. E-Commerce
- 11.3.6.2.1. By Value (USD Million) 2022-2032F
- 11.3.6.2.2. Market Share (%) 2022-2032F
- 11.3.6.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.6.3. Retail Pharmacy
- 11.3.6.3.1. By Value (USD Million) 2022-2032F
- 11.3.6.3.2. Market Share (%) 2022-2032F
- 11.3.6.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.6.4. Drug Store
- 11.3.6.4.1. By Value (USD Million) 2022-2032F
- 11.3.6.4.2. Market Share (%) 2022-2032F
- 11.3.6.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.7. By Purchasing Pattern
- 11.3.7.1. Prescription Drugs
- 11.3.7.1.1. By Value (USD Million) 2022-2032F
- 11.3.7.1.2. Market Share (%) 2022-2032F
- 11.3.7.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.7.2. Over-The-Counter Drugs
- 11.3.7.2.1. By Value (USD Million) 2022-2032F
- 11.3.7.2.2. Market Share (%) 2022-2032F
- 11.3.7.2.3. Y-o-Y Growth (%) 2022-2032F
- 12 North America Osteoarthritis Market Size & Forecast 2022A-2032F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Type
- 12.3.2. By Drug Type
- 12.3.3. By Diagnosis
- 12.3.4. By Route of Administration
- 12.3.5. By Treatment
- 12.3.6. By Distribution Channel
- 12.3.7. By Purchasing Pattern
- 12.4. Country
- 12.4.1. United States
- 12.4.2. Canada
- 13 Europe Osteoarthritis Market Size & Forecast 2022A-2032F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Type
- 13.3.2. By Drug Type
- 13.3.3. By Diagnosis
- 13.3.4. By Route of Administration
- 13.3.5. By Treatment
- 13.3.6. By Distribution Channel
- 13.3.7. By Purchasing Pattern
- 13.4. Country
- 13.4.1. Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14 Asia Osteoarthritis Market Size & Forecast 2022A-2032F
- 14.1. Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Type
- 14.3.2. By Drug Type
- 14.3.3. By Diagnosis
- 14.3.4. By Route of Administration
- 14.3.5. By Treatment
- 14.3.6. By Distribution Channel
- 14.3.7. By Purchasing Pattern
- 14.4. By Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15 Middle East and Africa Osteoarthritis Market Size & Forecast 2022A-2032F
- 15.1. Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Type
- 15.3.2. By Drug Type
- 15.3.3. By Diagnosis
- 15.3.4. By Route of Administration
- 15.3.5. By Treatment
- 15.3.6. By Distribution Channel
- 15.3.7. By Purchasing Pattern
- 15.4. Country
- 15.4.1. Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16 Latin America Osteoarthritis Market Size & Forecast 2022A-2032F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Type
- 16.3.2. By Drug Type
- 16.3.3. By Diagnosis
- 16.3.4. By Route of Administration
- 16.3.5. By Treatment
- 16.3.6. By Distribution Channel
- 16.3.7. By Purchasing Pattern
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17 Competitive Landscape
- 17.1. Company market share, 2021
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18 Company Profiles
- 18.1. Pfizer Inc
- 18.1.1. Company Overview
- 18.1.2. Financial Overview
- 18.1.3. Key Product; Analysis
- 18.1.4. Company Assessment
- 18.1.4.1. Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. Abbott
- 18.3. Novartis AG
- 18.4. Eli Lilly and Company
- 18.5. Bayer AG
- 18.6. Johnson & Johnson
- 18.7. ABIOGEN PHARMA S.p.A
- 18.8. Merck Sharp & Dohme Corp.
- 18.9. Apotex Inc.
- 18.10. TissueGene Inc.
- 18.11. Ampio Pharmaceuticals Inc.
- 18.12. Mylan N.V.
- 18.13. Tolmar Pharmaceuticals, Inc.
- 18.14. Other Prominent Players
- 19 Appendix
- 20 Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.